Aging and efficacy of disease-modifying therapies in multiple sclerosis: a meta-analysis of clinical trials

BACKGROUND: Disease-modifying therapies (DMTs) for multiple sclerosis (MS) are approved for the treatment of disease activity and are effective in reducing relapses and new magnetic resonance imaging (MRI) lesions. However, disease activity generally subsides with time, and age-dependent changes in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yinan, Gonzalez Caldito, Natalia, Shirani, Afsaneh, Salter, Amber, Cutter, Gary, Culpepper, William, Wallin, Mitchell, Kosa, Peter, Bielekova, Bibiana, Lublin, Fred, Stuve, Olaf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838219/
https://www.ncbi.nlm.nih.gov/pubmed/33552235
http://dx.doi.org/10.1177/1756286420969016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838219/
https://www.ncbi.nlm.nih.gov/pubmed/33552235
http://dx.doi.org/10.1177/1756286420969016

Ejemplares similares